Chroma Medicine Is A Biotechnology Company Located In Cambridgemassachusettsthe Company Is Dedicated To Developing A New Class Of Genomic Medicines That Leverage Epigenetics To Regulate Gene Expressionthis Innovative Approach Allows For Precise Control Over Gene Activity Without Changing The Dna Sequenceproviding A Promising Method For Addressing Genetically Driven Diseases The Company Specializes In Creating Epigenetic Editors That Can Silence Or Activate Genes Through Targeted Methylation And Demethylation Of Dnachroma Medicine Aims To Develop Single Dose Genomic Medicines That May Offer Long Lasting Or Even Lifelong Treatments For Various Conditionsthe Company Has Secured Substantial Fundingraising $125 Million In A Series A Round And An Additional $135 Million In Series B Financing In March 2023Highlighting Its Potential In The Biotechnology Sector
